Understanding How Common Metastatic Fallopian Tube Cancer Is
Fallopian tube cancer is remarkably rare among cancers affecting the female reproductive system. For many years, medical researchers believed it accounted for as few as 1% of all gynecological cancers, which are cancers that affect organs like the uterus, ovaries, cervix, and fallopian tubes. However, newer research has revealed something surprising: many cancers previously thought to start in the ovaries may actually begin in the fallopian tubes, particularly at the fimbriae, the finger-like ends of the tubes where eggs enter from the ovaries.[1]
When we talk about metastatic fallopian tube cancer, we mean cancer that has traveled from the fallopian tubes to other parts of the body. This typically occurs when the disease reaches Stage IV. Most people diagnosed with fallopian tube cancer don’t discover it until it has already spread, making metastatic disease unfortunately common among those who receive this diagnosis. The challenge lies in the fact that early-stage fallopian tube cancer rarely causes noticeable symptoms, and by the time symptoms appear, the cancer has often already begun its journey to other organs.[1]
More than half of all people diagnosed with fallopian tube cancer or its closely related cousin, ovarian cancer, are over 63 years old. The disease shows particular patterns in certain populations, being more common among people living in North America and those of Northern European or Ashkenazi Jewish descent.[1]
Where Fallopian Tube Cancer Spreads
Understanding where metastatic fallopian tube cancer travels helps explain why it becomes so difficult to treat. The cancer follows predictable pathways as it spreads through the body. Initially, if not caught early, cancer cells move from the fallopian tubes to nearby structures. The cancer may spread to the surface of the ovary and throughout the pelvis, the lower part of the abdomen that houses reproductive organs.[1]
As the disease progresses, it commonly causes peritoneal dissemination, meaning cancer cells scatter throughout the peritoneum, the thin tissue lining the abdominal wall and covering organs in the belly. Cancer cells may also reach the lymph nodes, small bean-shaped organs that are part of the immune system. When fallopian tube cancer spreads to lymph nodes, it typically affects those in the pelvis first, then may travel to paraaortic lymph nodes, which are located along the major blood vessel running through the abdomen.[4]
In more advanced metastatic cases, the cancer can reach distant organs. The lungs are a common destination, either as solid tumors in lung tissue or as fluid buildup around the lungs. The liver may also be affected, though it’s important to distinguish between cancer spreading to the surface of the liver versus growing inside the liver tissue itself. Less commonly, fallopian tube cancer can spread to unusual locations. There have been documented cases of the cancer appearing as large masses in the groin area, specifically in the inguinal lymph nodes, though such presentations are extremely rare.[4][7]
What Causes Fallopian Tube Cancer to Spread
Scientists don’t fully understand what triggers fallopian tube cancer to develop in the first place, which makes understanding its spread equally complex. What researchers do know is that approximately 90% of fallopian tube cancers develop in epithelial cells, the cells that line organs and glands throughout the body. These are the same types of cells where most ovarian cancers begin, which explains why the two diseases behave so similarly.[1]
Most fallopian tube cancers are classified as high-grade serous tumors. The term “high-grade” is significant because it describes how abnormal the cancer cells appear under a microscope and how quickly they multiply and spread. High-grade tumors are aggressive, meaning they grow and travel through the body rapidly. This aggressive nature is precisely what makes metastatic disease so common with fallopian tube cancer. By the time symptoms alert someone that something is wrong, the fast-growing cancer cells have often already broken away from the original tumor and begun establishing themselves in distant locations.[1]
The remaining fallopian tube cancers that don’t arise from epithelial cells start in connective tissue and are called sarcomas. These are even rarer but can also spread to distant sites.[1]
Who Is at Higher Risk for Metastatic Fallopian Tube Cancer
Several factors increase a person’s chances of developing fallopian tube cancer, which in turn increases the risk of facing metastatic disease since early detection is so challenging. Age stands out as the single most important risk factor, with most cases occurring in women over 63. However, younger women with certain genetic or family history factors also face elevated risks.[1]
Family history plays a crucial role in determining risk. If you have a first-degree biological relative—meaning a mother, sister, or daughter—who has had breast cancer, ovarian cancer, or fallopian tube cancer, your own risk increases substantially. This family connection often points to inherited genetic mutations that run in families.[1][5]
Speaking of genetics, changes or mutations in genes called BRCA1 and BRCA2 significantly raise the risk of fallopian tube cancer. These genes normally help prevent cancer by repairing damaged DNA in cells, but when they contain mutations, cells may grow out of control. Women with BRCA mutations face high enough risks that some choose preventive surgery to remove their fallopian tubes and ovaries before cancer develops.[1][5]
Certain inherited medical conditions also increase risk. Lynch syndrome, also called hereditary nonpolyposis colorectal cancer, and Peutz-Jeghers syndrome are both linked to higher rates of fallopian tube cancer. Additionally, women who have endometriosis, a condition where tissue similar to the uterine lining grows outside the uterus, face elevated risk.[1][5]
Reproductive history matters as well. Women who have never been pregnant or who had their first full-term pregnancy after age 35 are more likely to develop fallopian tube cancer. Similarly, getting your first menstrual period before age 12 or going through menopause after age 50 extends the number of years your body is exposed to hormones that may influence cancer development. Other risk factors include never having used hormonal birth control, having inflammation or infection of the fallopian tubes, obesity, and being tall, though researchers don’t fully understand why height correlates with increased risk.[1][2]
Recognizing Symptoms of Metastatic Fallopian Tube Cancer
One of the most frustrating aspects of fallopian tube cancer is that symptoms in the early stages are either absent or so subtle that they’re easy to dismiss. Many women only begin noticing clear symptoms after the cancer has already spread throughout the abdomen or to distant organs. The symptoms themselves can mimic common, benign conditions, which often leads to delays in seeking medical care or in receiving an accurate diagnosis.[1]
The most common symptoms include pain or a feeling of pressure in the pelvis, the area between your hip bones where reproductive organs sit. You might notice your abdomen becoming swollen or feeling bloated, even if you haven’t eaten much. This swelling can progress rapidly, sometimes over just days or weeks, as fluid accumulates in the abdominal cavity or as tumors grow. Some women describe a sensation of their organs feeling “crushed” or abnormally full.[1]
Changes in appetite are common, with many experiencing a loss of interest in food or feeling full after eating only small amounts. Nausea may accompany these eating changes. Your bathroom habits might shift as well—constipation or diarrhea can occur, and you may find yourself needing to urinate more frequently than usual. These symptoms happen because growing tumors or fluid buildup press against the intestines and bladder.[1][2]
Abnormal vaginal bleeding deserves immediate medical attention, especially if you’ve already gone through menopause. Some women notice unusual vaginal discharge that may be watery or tinged with blood. If you experience any sudden change in your health, particularly if you have known risk factors like a BRCA mutation or family history of gynecologic cancers, don’t hesitate to contact your healthcare provider.[1][2]
How Doctors Prevent and Screen for This Cancer
Unfortunately, there are currently no reliable screening tests for fallopian tube cancer that doctors recommend for women at average risk. Unlike breast cancer, which can be screened with mammograms, or cervical cancer, which can be detected through Pap tests, fallopian tube cancer lacks an effective early detection method for the general population. This absence of screening tools is one reason why so many cases are diagnosed only after the cancer has already metastasized.[1]
However, women at significantly high risk—particularly those with BRCA1 or BRCA2 mutations—do have options to reduce their chances of developing fallopian tube cancer. The most effective prevention strategy for high-risk women is preventive surgery to remove the fallopian tubes and ovaries, procedures called salpingectomy and oophorectomy. While this may sound drastic, for women with BRCA mutations, this surgery can dramatically lower the risk of both fallopian tube and ovarian cancer. Many high-risk women choose to undergo this surgery after they’ve completed childbearing or around age 40.[1][5]
Lifestyle factors may play a role in prevention, though the evidence isn’t as strong as it is for some other cancers. Some research suggests that using oral contraceptives (birth control pills) may reduce risk, as can having children and breastfeeding. These factors seem to lower risk by reducing the total number of times a woman ovulates during her lifetime, though scientists are still working to understand the exact mechanisms involved.[1]
For women with a strong family history or known genetic mutations, regular monitoring by a gynecologic oncologist—a doctor who specializes in reproductive system cancers—is essential. While imaging tests like transvaginal ultrasound or blood tests measuring CA-125, a protein that can be elevated in ovarian and fallopian tube cancers, are sometimes used to monitor high-risk women, these tests are not perfect and can miss early cancers or cause false alarms.[5]
What Happens in the Body When Cancer Spreads
Understanding the changes that occur in your body when fallopian tube cancer becomes metastatic helps explain both the symptoms you might experience and the treatments doctors recommend. The process of metastasis—cancer spreading from its original location to distant sites—involves several steps at the cellular and biological level.[7]
Normal, healthy cells in the fallopian tubes follow strict rules about when to grow, divide, and die. Cancer develops when genetic changes cause cells to ignore these rules. In fallopian tube cancer, cells in the epithelial lining of the tubes begin multiplying uncontrollably, forming a tumor. As the tumor grows, cancer cells at its edges can break away and enter nearby spaces.[1]
Because the fallopian tubes sit in the peritoneal cavity, a space lined with peritoneum tissue and containing a small amount of fluid, cancer cells can easily float through this fluid and land on other organs. This explains why peritoneal dissemination is so common with fallopian tube cancer. The cells essentially “seed” themselves throughout the abdomen, establishing new tumor sites on the peritoneum, the surface of the liver, the intestines, and other abdominal organs.[7]
Cancer cells can also travel through the lymphatic system, a network of vessels and nodes that normally helps fight infection and maintain fluid balance. When cancer cells enter lymph vessels, they’re carried to lymph nodes, where they may lodge and grow. This lymphatic spread is how cancer reaches nodes in the pelvis and along the aorta, the body’s largest artery.[4]
In more advanced cases, cancer cells enter the bloodstream and travel to distant organs like the lungs or areas inside the liver. Once established in these new locations, the cancer cells continue to grow and multiply, forming new tumors that interfere with the normal function of those organs. For example, cancer in the lungs can make breathing difficult, while cancer affecting the liver can interfere with the organ’s ability to filter blood and produce important proteins.[7]
The body often responds to widespread cancer with systemic effects. Fluid may accumulate in the abdomen, a condition called ascites, as the peritoneal lining becomes irritated by tumor deposits. The immune system attempts to fight the cancer, but unfortunately, cancer cells have developed ways to evade immune detection. Meanwhile, tumors may produce substances that affect appetite, cause fatigue, or lead to weight loss, contributing to the overall decline in wellbeing that many people with metastatic cancer experience.[7]
